Human management

Global Veterinary Pain Management Market Overview to 2027

DUBLIN, April 7, 2022 /PRNewswire/ — The “Veterinary Pain Management Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” report has been added to from ResearchAndMarkets.com offer.

The global veterinary pain management market has reached a value of US$1.28 billion in 2021. Looking ahead, the publisher expects the market to reach a value of US$1.97 billion by 2027 exhibiting a CAGR of 7.0% over the period 2022-2027. Keeping in mind the uncertainties of COVID-19, we continuously monitor and assess the direct and indirect influence of the pandemic. This information is included in the report as a major market contributor.

Veterinary pain management refers to various drugs and drug combinations given to animals to relieve chronic pain. It involves observing behavioral cues and anticipating the type, severity and duration of pain. Treatment includes physical compresses, massage, therapy, rehabilitation, acupuncture, laser therapy, and the administration of therapeutic and anti-anxiety medications. These drugs can be administered orally, parenterally or topically. Veterinary pain management involves implementing changes in housing conditions, diet, and level of interaction with other animals and humans. It is effective against acute surgical, traumatic and disease-related pain and also helps to improve the overall health of the animal.

Veterinary Pain Management Market Trends:

The increasing domestication of animals, along with the growing awareness of animal health among the masses, is one of the key factors driving the growth of the market. Additionally, the convenient availability of pain management products and devices including opioids, nonsteroidal anti-inflammatory drugs (NSAIDs), laser devices, and local anesthetics is driving the growth of the market. These solutions relieve pain caused by musculoskeletal disorders, pain induced by radiotherapy, chemotherapy, osteoarthritis and mastitis.

In this light, the widespread adoption of laser therapy as an effective solution for pain management is also contributing to the growth of the market. Laser therapy provides significant pain relief and also helps regenerate nerve tissue after surgery. Additionally, a significant rise in the population of cattle suffering from cancer, abdominal and neuropathic pain is also creating a positive outlook for the market. Other factors including the growing prevalence of inflammatory and painful diseases in pets, along with the widespread adoption of pet insurance services, are expected to drive the market towards growth.

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the major players being Assisi Animal Health, Bayer AG, Boehringer Ingelheim International GmbH (CH Boehringer Sohn AG & Co. KG), Ceva Sante Animale, Chanelle Pharma, Dechra Pharmaceuticals PLC, Eli Lilly and Company, Idexx Laboratories Inc., Merck & Co. Inc., Norbrook, Vetoquinol SA and Zoetis Inc.

Answers to key questions in this report:

  • How has the global veterinary pain management market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global veterinary pain management market?
  • What are the main regional markets?
  • What is the market breakdown by product?
  • What is the breakdown of the market according to the type of animal?
  • What is the market breakdown by application?
  • What is the market breakdown by end user?
  • What are the different stages of the industry value chain?
  • What are the key drivers and challenges in the industry?
  • What is the structure of the global veterinary pain management market and who are the key players?
  • How competitive is the industry?

Main topics covered:

1 Preface

2 Scope and methodology

3 Executive summary

4 Presentation
4.1 Overview
4.2 Key Industry Trends

5 Global Veterinary Pain Management Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakdown by Product
6.1 Medicines
6.1.1 Market trends
6.1.2 Key segments
6.1.2.1 NSAIDs
6.1.2.2 Anesthetics
6.1.2.3 Opioids
6.1.2.4 Other drugs
6.1.3 Market Forecast
6.2 Devices
6.2.1 Market trends
6.2.1 Key segments
6.2.1.1 Laser therapy
6.2.1.2 Electromagnetic therapy
6.2.2 Market Forecast

7 Market Breakdown by Animal Type
7.1 Companion
7.1.1 Market trends
7.1.2 Market Forecast
7.2 Livestock
7.2.1 Market trends
7.2.2 Market Forecast

8 Market Breakdown by Application
8.1 Osteoarthritis and joint pain
8.1.1 Market trends
8.1.2 Market Forecast
8.2 Postoperative pain
8.2.1 Market trends
8.2.2 Market Forecast
8.3 Cancer
8.3.1 Market trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market trends
8.4.2 Market Forecast

9 Market Breakdown by End User
9.1 Hospitals and clinics
9.1.1 Market trends
9.1.2 Market Forecast
9.2 Others
9.2.1 Market trends
9.2.2 Market Forecast

10 Market Breakdown by Region

11 SWOT Analysis

12 Value chain analysis

13 Analysis of the five forces of carriers

14 Price Analysis

15 Competitive landscape
15.1 Market structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Animal Health Base
15.3.1.1 Company overview
15.3.1.2 Product portfolio
15.3.2 Bayer AG
15.3.2.1 Presentation of the company
15.3.2.2 Product portfolio
15.3.2.3 Finance
15.3.2.4 SWOT Analysis
15.3.3 Boehringer Ingelheim International GmbH (CH Boehringer Sohn AG & Co. KG)
15.3.3.1 Company overview
15.3.3.2 Product portfolio
15.3.4 Ceva Animal Health
15.3.4.1 Company Overview
15.3.4.2 Product portfolio
15.3.5 Chanel Pharma
15.3.5.1 Company Overview
15.3.5.2 Product portfolio
15.3.6 Dechra Pharmaceuticals PLC
15.3.6.1 Company Overview
15.3.6.2 Product portfolio
15.3.6.3 Finance
15.3.7 Eli Lilly and company
15.3.7.1 Company Overview
15.3.7.2 Product portfolio
15.3.7.3 Finance
15.3.7.4 SWOT Analysis
15.3.8 Idexx Laboratories Inc.
15.3.8.1 Company Overview
15.3.8.2 Product portfolio
15.3.8.3 Finance
15.3.8.4 SWOT Analysis
15.3.9 Merck & Co. Inc.
15.3.9.1 Company Overview
15.3.9.2 Product portfolio
15.3.9.3 Finance
15.3.9.4 SWOT Analysis
15.3.10 Norbrook
15.3.10.1 Company Overview
15.3.10.2 Product portfolio
15.3.11 Vetoquinol SA
15.3.11.1 Company Overview
15.3.11.2 Product portfolio
15.3.11.3 Finance
15.3.12 Zoetis Inc.
15.3.12.1 Company overview
15.3.12.2 Product portfolio
15.3.12.3 Finance
15.3.12.4 SWOT Analysis

For more information on this report, visit https://www.researchandmarkets.com/r/zgo2go

Media Contact:

Research and Markets
Laura Woodsenior
[email protected]

For EST office hours, call +1-917-300-0470
For USA/CAN call toll free +1-800-526-8630
For GMT office hours call +353-1-416-8900

US Fax: 646-607-1907
Fax (outside the US): +353-1-481-1716

SOURCE Research and Markets